Absci Corporation (ABSI) Financials
ABSI Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 236.3 million | 39.9 million |
2023-06-30 | 254.2 million | 38.8 million |
2023-03-31 | 295.8 million | 41.8 million |
2022-12-31 | 321.0 million | 46.6 million |
ABSI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -10.7 million | 2.5 million |
2023-06-30 | -19.5 million | 3.0 million |
2023-03-31 | -20.4 million | 2.7 million |
2022-12-31 | -19.1 million | 1.0 million |
ABSI Net Income
No data available :(
ABSI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 113.5 million | - | 9.0 million |
2023-06-30 | 124.6 million | 6.4 million | 9.9 million |
2023-03-31 | 144.3 million | 7.2 million | 11.0 million |
2022-12-31 | 164.4 million | - | 12.1 million |
ABSI Shares Outstanding
ABSI Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 307000 | 11.0 million | 9.5 million | - |
2023-06-30 | 256000 | 12.1 million | 9.4 million | - |
2023-03-31 | 280000 | 12.7 million | 9.6 million | - |
2022-12-31 | 560000 | 11.3 million | 7.7 million | - |
ABSI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 744000 | 3.5 million |
2023-06-30 | 3.4 million | 3.5 million |
2023-03-31 | 1.3 million | 3.5 million |
2022-12-31 | 1.6 million | 3.6 million |
ABSI
Price: $5.08
52 week price:
Earnings Per Share: -1.20 USD
P/E Ratio: -3.71
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 382100
Market Capitalization: 579.7 million